Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.50
-0.77 (-2.91%)
Streaming Delayed Price
Updated: 11:58 AM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
99
100
Next >
Is Pfizer Stock a Buy Now?
October 03, 2023
Pfizer shares have dropped 35% this year.
Via
The Motley Fool
3 Massively Undervalued Dividend Stocks to Buy for High Total Returns
October 02, 2023
Smart investors should plan to buy these undervalued dividend stocks with a valuation gap for high total returns in the next 12 to 15 months.
Via
InvestorPlace
The Latest Analyst Ratings for Pfizer
October 02, 2023
Via
Benzinga
Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024
October 02, 2023
The stars are aligning for these pharmaceutical giants, making their stocks look ready to run higher in next year.
Via
InvestorPlace
3 Top Stocks to Buy in October and Hold Forever
October 02, 2023
Check out these three blue chip buys playing crucial roles in America's $6 trillion healthcare opportunity.
Via
The Motley Fool
Nobel Prize Honors Scientists Behind mRNA Vaccines Against Covid-19
October 02, 2023
Discover the remarkable journey of Nobel Prize laureates Kariko and Weissman, who transformed medicine with mRNA vaccines, and the financial impact on Moderna and Pfizer stocks.
Via
Benzinga
Is NYSE:PFE a Good Fit for Dividend Investing?
October 02, 2023
Is PFIZER INC (NYSE:PFE) suited for dividend investing?
Via
Chartmill
Where Will Pfizer Be in 5 Years?
September 29, 2023
Investors should expect to see big changes from the company as it addresses concerns about its growth prospects.
Via
The Motley Fool
Is NYSE:PFE suited for dividend investing?
September 29, 2023
Why the dividend investor may take a look at PFIZER INC (NYSE:PFE).
Via
Chartmill
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
October 02, 2023
Read the latest report on NanoViricides here
Via
Benzinga
3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street
October 01, 2023
Analysts like these stocks for very good reasons.
Via
The Motley Fool
Moderna's Shares Could Take Off if These 2 Things Happen
September 30, 2023
Moderna stock soared early in the pandemic.
Via
The Motley Fool
Why Pfizer and BioNTech Stocks Zoomed Higher Today
September 29, 2023
The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle.
Via
The Motley Fool
Exposures
COVID-19
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
September 29, 2023
Investors are constantly on the hunt for undervalued, under-followed, and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance...
Via
Benzinga
5 Stocks That Have Massive Upside According to Analysts
September 28, 2023
Analyst ratings are frequently a solid predictor of future stock price movement; here are five stocks that analysts believe have massive upside.
Via
MarketBeat
After Achieving 100% Cancer Remission Rates In Preclinical Studies, Starpax Magnetodrones Head For Human Trials
September 28, 2023
--News Direct--
Via
News Direct
Topics
Death
Exposures
Death
Smart Picks: 7 Blue-Chips Trading Below True Value
September 28, 2023
Undervalued blue-chip stocks make more sense than ever as the tech sell off causes a pivot into more conservative shares.
Via
InvestorPlace
Kevin Dodelande's iMi launches into early cancer detection
September 28, 2023
In this age of technological advances, the power of Big Data combined with Artificial Intelligence (AI) is opening up new possibilities through early diagnosis to increase patient life expectancy.
Via
IssueWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher
September 27, 2023
These pharma stocks could boom in the coming years, riding their diversified pipelines with massive addressable markets higher.
Via
InvestorPlace
Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the Mold
September 27, 2023
Stifel initiated coverage on Nuvalent Inc (NASDAQ: NUVL), recognizing that adopting a bullish stance in anticipation of Phase 1 cancer drug data, mainly when derived from heavily pretreated patients,...
Via
Benzinga
Why Pfizer Stock Hit A New 52-Week Low Today
September 27, 2023
Pfizer, Inc. (NYSE: PFE) shares are trading lower Wednesday. The stock hit a new 52-week low and has fallen more than 24% over the last year. What To Know:
Via
Benzinga
What's Going On Pfizer's Subsidiary Biohaven Stock?
September 27, 2023
Pfizer Inc's (NYSE: PFE) subsidiary Biohaven Ltd (NYSE: BHVN) released an
Via
Benzinga
Why Ginkgo Bioworks Stock Is Surging Higher Today
September 27, 2023
A new collaboration with Pfizer is fueling a rally in the company's shares today.
Via
The Motley Fool
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
September 27, 2023
U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria. More than a million people worldwide succumb to infections caused...
Via
Benzinga
Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine
September 27, 2023
Pharma companies across the globe, including Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA), are harnessing the potential of mRNA which is creating plenty of space for scientific improvement in...
Via
Benzinga
These 2 Stocks Are Getting Smart Investors' Attention Wednesday
September 27, 2023
Big movers in either direction can give hints about broader market sentiment.
Via
The Motley Fool
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
September 27, 2023
Benzinga Alibaba's Logistics Arm Cainiao Files For Hong Kong IPO
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Pfizer Is Sending Ginkgo Bioworks (DNA) Stock Higher: Here's Why
September 27, 2023
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Wednesday after the company announced a collaboration with Pfizer Inc (NYSE: PFE) focused on the
Via
Benzinga
DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer
September 27, 2023
The deal keeps Ginkgo alive, but its business model of becoming the "Apple Store of Biotech" remains unproven. DNA stock jumped overnight.
Via
InvestorPlace
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
September 27, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.